169 related articles for article (PubMed ID: 10448804)
1. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
Arch Neurol; 1999 Aug; 56(8):982-9. PubMed ID: 10448804
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Takahashi H; Snow BJ; Bhatt MH; Peppard R; Eisen A; Calne DB
Lancet; 1993 Oct; 342(8878):1016-8. PubMed ID: 8105264
[TBL] [Abstract][Full Text] [Related]
3. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
4. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
Ernst M; Zametkin AJ; Matochik JA; Pascualvaca D; Jons PH; Cohen RM
Am J Psychiatry; 1999 Aug; 156(8):1209-15. PubMed ID: 10450262
[TBL] [Abstract][Full Text] [Related]
5. [Positron-emission tomographic study of the dopaminergic system in a case of secondary unilateral tremor after mesencephalic hematoma].
De Recondo A; Rondot P; Loc'h C; Crouzel C; Dao-Castellana MH; Bathien NG; Rascol O; Clanet M; De Recondo J; Samson Y
Rev Neurol (Paris); 1993; 149(1):46-9. PubMed ID: 8337562
[TBL] [Abstract][Full Text] [Related]
6. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Snow BJ; Bhatt M; Martin WR; Li D; Calne DB
J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):12-7. PubMed ID: 1901347
[TBL] [Abstract][Full Text] [Related]
7. [123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia.
Naumann M; Pirker W; Reiners K; Lange K; Becker G; Brücke T
Mov Disord; 1997 May; 12(3):448-51. PubMed ID: 9159746
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Nygaard TG; Takahashi H; Heiman GA; Snow BJ; Fahn S; Calne DB
Ann Neurol; 1992 Nov; 32(5):603-8. PubMed ID: 1449240
[TBL] [Abstract][Full Text] [Related]
9. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
Pate BD; Kawamata T; Yamada T; McGeer EG; Hewitt KA; Snow BJ; Ruth TJ; Calne DB
Ann Neurol; 1993 Sep; 34(3):331-8. PubMed ID: 8363350
[TBL] [Abstract][Full Text] [Related]
10. Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy.
Lewerenz J; Zurowski B; Jenicke L; Bäumer T; Lees AJ; Münchau A
Mov Disord; 2005 Aug; 20(8):1071-5. PubMed ID: 15838851
[TBL] [Abstract][Full Text] [Related]
11. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
Rakshi JS; Uema T; Ito K; Bailey DL; Morrish PK; Ashburner J; Dagher A; Jenkins IH; Friston KJ; Brooks DJ
Brain; 1999 Sep; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
Snow BJ; Nygaard TG; Takahashi H; Calne DB
Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569
[TBL] [Abstract][Full Text] [Related]
13. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
14. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
17. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
Otsuka M; Ichiya Y; Shima F; Kuwabara Y; Sasaki M; Fukumura T; Kato M; Masuda K; Goto I
J Neurol Sci; 1992 Sep; 111(2):195-9. PubMed ID: 1431986
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preliminary evaluation of (S)-(2-[18F]fluoro-4,5-dihydroxyphenyl)-2-methyl L-alanine, (S)-[18F]-FMEDOPA, a potentially improved imaging agent for the presynaptic dopaminergic nervous system.
Yost Y; Conway T
Nucl Med Biol; 1996 Oct; 23(7):857-65. PubMed ID: 8971852
[TBL] [Abstract][Full Text] [Related]
19. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
